Prudential Financial, Inc. 13D and 13G filings for Arcutis Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 3:58 pm Purchase |
2024-02-14 | 13G | Arcutis Biotherapeutics, Inc. ARQT |
PRUDENTIAL FINANCIAL INC PRU |
9,884,137 10.470% |
233,326 (+2.42%) |
Filing |
| 2023-11-09 2:54 pm Purchase |
2023-11-09 | 13G | Arcutis Biotherapeutics, Inc. ARQT |
PRUDENTIAL FINANCIAL INC PRU |
9,650,811 10.250% |
9,650,811 (New Position) |
Filing |